Thermo Fisher Scientific Inc., a major global player in the life sciences sector, has announced plans to invest $2 billion in its U.S. operations over the next four years. The investment is aimed at bolstering American innovation, enhancing manufacturing capacity,
Johnson & Johnson has announced a $55 billion investment in U.S. manufacturing, research, and technology over the next four years, marking a 25% increase over the previous period. The initiative builds upon the company’s existing U.S. investment levels, which were elevated
Pfizer is prepared to adapt if pharmaceutical tariffs are introduced under a second Trump administration, CEO Albert Bourla, Ph.D., said at TD Cowen’s 45th annual healthcare conference in Boston. The company already operates 13 manufacturing sites across the U.S. and could
